Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Use of Hydralazine and Valproic Acid in Advanced Solid Tumor Malignancies

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
New Mexico Cancer Care Alliance
ClinicalTrials.gov Identifier:
NCT00996060
First received: March 26, 2009
Last updated: January 15, 2016
Last verified: January 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: January 2013
  Primary Completion Date: December 2012 (Final data collection date for primary outcome measure)